Such targets are either in early phases of clinical trials or have been identified as candidates following detailed experimental study.
Prominent anti-parasite vaccine candidates have been identified through the Human Hookworm Vaccine Initiative and include a family of pathogenesis-related (PR) proteins, such as the Ancylostoma -secreted proteins (ASPs) [59].